ViiV Healthcare, a GSK-majority-owned HIV specialist, has committed to making at least two million doses of its long-acting ...

Texas Attorney General Ken Paxton has filed a lawsuit against pharmaceutical companies, including Eli Lilly, and pharmacy ...

Cambridge, USA-based biotech Judo Bio has announced the company’s launch and $100 million in initial financing, including ...

Orum Therapeutics, specializing in degrader-antibody conjugates, has filed for a $67 million IPO on South Korea's Kosdaq. The ...

South Korea’s ABL Bio Corp (KS: 298380) on Friday revealed that it has entered into a clinical trial collaboration and supply ...

ViroCell Biologics, a UK contract development and manufacturing organization (CDMO), has announces the appointment of ...

US pharma giant Pfizer (NYSE: PFE) has announced that John McGinley has been appointed UK managing director and country ...

AstraZeneca's Airsupra (albuterol/budesonide) met the primary endpoint in the Phase III BATURA trial, significantly reducing ...

The Irish Healthcare Association (IPHA), the representative body for the research-based biopharmaceutical industry in ...

US healthcare giant Johnson & Johnson (NYSE: JNJ) revealed it is discontinuing the Phase II field study (NCT05201794) ...

India's new Biotechnology Research Innovation and Entrepreneurship Development (Bio-RIDE) scheme is a significant step ...

AstraZeneca has entered into an exclusive license agreement with China’s CSPC Pharmaceutical to advance the development of an ...